Opendata, web and dolomites

CERVINO SIGNED

Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics?

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CERVINO project word cloud

Explore the words cloud of the CERVINO project. It provides you a very rough idea of what is the project "CERVINO" about.

cells    characterise    inspire    endometrial    compromise    innovators    instead    sequencing    showed    biopsy    had    ecs    single    genome    revealed    vitro    transfer    demonstrated    quality    pgs    consequently    transcriptome    harmful    introduce    methodology    rnaseq    transcriptomic    release    human    abundance    genes    utilising    natural    host    select    edge    biosafety    material    pathophysiology    throughput    cell    mechanistic    consequence    therapeutic    fertilisation    whereby    uterine    time    receptivity    potentially    invasive    internalised    biomarkers    effect    evs    cutting    ivf    delineating    upregulation    prior    embryos    paramount    aneuploid    primary    therapeutics    function    additionally    establishment    controversial    negate    tackle    vesicles    genetic    profile    screening    pilot    mount    biopsies    exported    community    collectively    internalisation    implantation    acquisition    scrutinise    group    embryo    euploid    reported    utilised    functional    screen    extracellular    potentiates    first    preimplantation    poor    gene    cargo    ev   

Project "CERVINO" data sheet

The following table provides information about the project.

Coordinator
OSPEDALE SAN RAFFAELE SRL 

Organization address
address: VIA OLGETTINA 60
city: MILANO
postcode: 20132
website: www.hsr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 180˙277 €
 EC max contribution 180˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-07-02   to  2020-07-01

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSPEDALE SAN RAFFAELE SRL IT (MILANO) coordinator 180˙277.00

Map

 Project objective

Preimplantation Genetic Screening (PGS) based on high-throughput embryo genome sequencing is currently utilised in In Vitro Fertilisation (IVF) to select for euploid embryos prior to uterine transfer in order to increase implantation potential. The methodology for the acquisition of genetic material is controversial, as the invasive embryo biopsy required for PGS may compromise embryo quality. Moreover its long-term biosafety has not been evaluated. Consequently, the development of non-invasive methods to screen out aneuploid embryos is paramount. The host research group recently first reported that human IVF embryos release extracellular vesicles (EVs) and demonstrated their uptake by primary endometrial cells (ECs). Our pilot analysis of the embryo-derived EV transcriptome revealed an abundance of genes that may be involved in the establishment of endometrial receptivity. Additionally, our RNAseq on ECs, which had internalised human embryo-exported EVs, showed a gene-upregulation profile relevant to implantation. Collectively, our findings introduce a novel concept to the state-of-the-art whereby human embryos deliver a functional EV-transcriptomic cargo to ECs to mount an implantation response. Delineating the EV transcriptome, and studying the consequence of its delivery in ECs, potentiates mechanistic insight into the pathophysiology of implantation. The project will characterise for the first time the transcriptomic cargo of euploid and aneuploid human embryo-exported EVs and scrutinise the effect of its internalisation on endometrial function. This cutting-edge work may negate potentially harmful invasive embryo biopsies for PGS by instead utilising biomarkers in EVs – a ‘natural cell biopsy’. EV biomarkers could also inspire therapeutics to enhance endometrial receptivity. This programme is especially timely, as leading innovators in the field currently focus to provide the community with a single therapeutic approach to tackle poor endometrial function.

 Publications

year authors and title journal last update
List of publications.
2018 Sofia Makieva, Elisa Giacomini, Jessica Ottolina, Ana Sanchez, Enrico Papaleo, Paola Viganò
Inside the Endometrial Cell Signaling Subway: Mind the Gap(s)
published pages: 2477, ISSN: 1422-0067, DOI: 10.3390/ijms19092477
International Journal of Molecular Sciences 19/9 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CERVINO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CERVINO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Photonic Radar (2019)

Implementation of Long Reach Hybrid Photonic Radar System and convergence over FSO and PON Networks

Read More  

CORRELATION (2020)

Characterization and prediction of service-level traffic for future sliced mobile network

Read More  

RegulatioNFkB (2019)

Deciphering transcriptional regulation of NF-kB target genes using integrative omics approaches

Read More